Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by carduon May 24, 2010 1:58pm

570 Views

Post# 17126526

RE: RE: RE: naysayers

"My explanation is that there is a major trader who is influencing the market by trading to suppress the price."

The $64000 question is WHY? Is it to accumulate shares at a snail's pace, given the low volume? Is it to keep the price down so that BT can't get a decent PP done to enhance the coffers of the company, thus, opening up a cheap takeover? At my age I have absolutely no illusions left as to the lengths MMs will go to screw the investor. Anything goes with those b******s.

My feelings about "the market" can be summed up by the comment Sean Connery gave about his dealings with the Hollywood elites," I've been screwed more times than a wh*re".

Bullboard Posts

Arbor Metals completes Phase 1 drilling at Jarnet lithium project